日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

TRIM13 in situ engineering boosts anti-inflammatory capacity of CAR-Ms for liver fibrosis therapy

TRIM13原位工程改造增强CAR-Ms的抗炎能力,用于肝纤维化治疗

Gao, Jinxin; Yang, Zhenmei; Song, Yudong; Shao, Lijuan; Dong, Xianghui; Li, Caiping; Bo, Longyu; Zhao, Xiaotian; Han, Maosen; Tang, Chunwei; Fu, Zhipeng; Dai, Kuan; Li, Yintao; Li, Na; Li, Tao; Chen, Chen; Jiang, Xinyi; Zhao, Kun

Catgut implantation at acupoints improves anti-PD-1 inhibitor efficacy in lung cancer by inducing immune responses and remodeling the tumor microenvironment.

在穴位植入羊肠线可通过诱导免疫反应和重塑肿瘤微环境来提高抗PD-1抑制剂在肺癌中的疗效。

Wu Qian, Su Ting, Zhang Yuanyuan, Xiong Yuerong, Hu Xiaoyan, Shao Lijuan, Chen Size

Synthetic efferocytic receptor microglia enhances anti-inflammatory clearance of amyloid-β for AD treatment in mice.

合成吞噬受体小胶质细胞增强抗炎清除淀粉样蛋白β的功效,用于治疗小鼠的阿尔茨海默病

Shao Lijuan, Zhang Yi, Yang Zhenmei, Shi Chongdeng, Yue Xiao, Li Caiping, Liu Ying, Fu Zhipeng, Tang Chunwei, Zhao Xiaotian, Han Maosen, Zhang Jing, Sun Weiyi, Yao Zichao, Xi Kaiyan, Fang Zezheng, Wang Zixu, Feng Fan, Ma Chunhong, Zhao Kun, Zhang Yulin, Ni Shilei, Jiang Xinyi, Chen Chen

In-depth analysis of the safety of CAR-T cell therapy for solid tumors

对CAR-T细胞疗法治疗实体瘤的安全性进行深入分析

Dong, Jiayi; Wu, Jiexiong; Jin, Ye; Zheng, Zhu; Su, Ting; Shao, Lijuan; Bei, Jiaxin; Chen, Size

Causal inference of CLEC5A and ISG20 in atherosclerosis: integrating Mendelian randomization and eQTL evidence

CLEC5A 和 ISG20 在动脉粥样硬化中的因果推断:整合孟德尔随机化和 eQTL 证据

Zhang, Ya; Tian, Qian; Zhu, Yuan; Wang, Tianhui; Yu, Yongchao; Wang, Lan; Shao, Lijuan; Mo, Xiangang

SLC4A7 suppresses lung adenocarcinoma oncogenesis by reducing lactate transport and protein lactylation.

SLC4A7 通过减少乳酸转运和蛋白质乳酸化来抑制肺腺癌的发生

Yan Haojie, He Qian, Gao Yubiao, He Xiaomei, Luo Haitao, Shao Lijuan, Dong Jun, Li Furong

NHE1 in macrophages promotes octanal/Olfr2-induced atherosclerosis via calcium-dependent ROS and NLRP3 inflammasome activation

巨噬细胞中的NHE1通过钙依赖性ROS和NLRP3炎症小体激活促进辛醛/Olfr2诱导的动脉粥样硬化。

Wang, Tianhui; Wang, Lan; Tian, Qian; Zhu, Yuan; Shao, Lijuan; Zeng, Jiao; Yu, Yongchao; Li, Zhonglian; Su, Xiaomeng; Chen, Juhai; Zhang, Ya; Mo, Xiangang

Drug functional remapping: a new promise for tumor immunotherapy

药物功能重映射:肿瘤免疫疗法的新希望

Dong, Jiayi; Su, Ting; Wu, Jiexiong; Xiang, Yu; Song, Minghan; He, Canfeng; Shao, Lijuan; Yang, Yubin; Chen, Size

Chimeric antigen receptor natural killer cell therapy for solid tumors: mechanisms, clinical progress, and strategies to overcome the tumor microenvironment

嵌合抗原受体自然杀伤细胞疗法治疗实体瘤:机制、临床进展及克服肿瘤微环境的策略

Xiang, Yu; Dong, Jiayi; Shao, Lijuan; Chen, Size

Analysis on benzothiazole necroptosis inhibitors with chiral substitutions in the solvent-accessible region of RIP kinase domain

RIP激酶结构域溶剂可及区域手性取代的苯并噻唑类坏死凋亡抑制剂分析

Hongming Shao, Lijuan Xu, Gechang Li, Shuyu Wang, Ting Han, Chunlin Zhuang